Start Submission Become a Reviewer

Reading: Ultrasound contrast agent delivered per os first diagnoses pharyngoesophageal tumour

Download

A- A+
Alt. Display

Original Article

Ultrasound contrast agent delivered per os first diagnoses pharyngoesophageal tumour

Authors:

E Antypa ,

Radiology Department, Evangelismos Hospital, Athens, Greece, GR
X close

DD Cokkinos,

Radiology Department, Evangelismos Hospital, Athens, Greece, GR
X close

I Kalogeropoulos,

Radiology Department, Evangelismos Hospital, Athens, Greece, GR
X close

D Tomais,

Radiology Department, Evangelismos Hospital, Athens, Greece, GR
X close

PN Piperopoulos

Radiology Department, Evangelismos Hospital, Athens, Greece, GR
X close

Abstract

Oral administration of ultrasound contrast agents has been described very little so far in medical literature. These agents are mainly administered intravenously and, less commonly, intracavitarily. We present the case of a patient with a cervical mass in whom sonographic examination with per os administration of SonoVue led to the diagnosis of a pharyngoesophageal tumour. The diagnosis was confirmed on barium swallow and endoscopy-guided biopsy.

How to Cite: Antypa E, Cokkinos D, Kalogeropoulos I, Tomais D, Piperopoulos P. Ultrasound contrast agent delivered per os first diagnoses pharyngoesophageal tumour. Journal of the Belgian Society of Radiology. 2013;96(2):69–71. DOI: http://doi.org/10.5334/jbr-btr.211
13
Views
8
Downloads
Published on 01 Mar 2013.
Peer Reviewed

Downloads

  • PDF (EN)

    comments powered by Disqus